anmelden
Novo Nordisk Aktie
33,61
EUR
-0,42
EUR
-1,22
%
33,85
EUR
+0,10
EUR
+0,28
%
Novo Nordisk jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Novo Nordisk Aktie Analyse
| 06.01.25 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 06.01.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 23.12.24 | Novo Nordisk Overweight | Barclays Capital | |
| 23.12.24 | Novo Nordisk Halten | DZ BANK | |
| 20.12.24 | Novo Nordisk Underperform | Bernstein Research | |
| 20.12.24 | Novo Nordisk Neutral | UBS AG | |
| 20.12.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 17.12.24 | Novo Nordisk Buy | Deutsche Bank AG | |
|
Werbung
|
|||
| 16.12.24 | Novo Nordisk Neutral | UBS AG | |
| 16.12.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 12.12.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 10.12.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 09.12.24 | Novo Nordisk Neutral | UBS AG | |
| 09.12.24 | Novo Nordisk Underperform | Bernstein Research | |
| 04.12.24 | Novo Nordisk Underperform | Bernstein Research | |
| 04.12.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 03.12.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 02.12.24 | Novo Nordisk Neutral | UBS AG | |
| 01.12.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 27.11.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 27.11.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 18.11.24 | Novo Nordisk Neutral | UBS AG | |
| 15.11.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 13.11.24 | Novo Nordisk Neutral | UBS AG | |
| 11.11.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 11.11.24 | Novo Nordisk Neutral | UBS AG | |
| 11.11.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 11.11.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 08.11.24 | Novo Nordisk Overweight | Barclays Capital | |
| 07.11.24 | Novo Nordisk Neutral | UBS AG | |
| 07.11.24 | Novo Nordisk Halten | DZ BANK | |
| 07.11.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 07.11.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 06.11.24 | Novo Nordisk Neutral | UBS AG | |
| 06.11.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 06.11.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 06.11.24 | Novo Nordisk Neutral | UBS AG | |
| 06.11.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 04.11.24 | Novo Nordisk Neutral | UBS AG | |
| 04.11.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 04.11.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 01.11.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 31.10.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 30.10.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 28.10.24 | Novo Nordisk Neutral | UBS AG | |
| 22.10.24 | Novo Nordisk Halten | DZ BANK | |
| 21.10.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 21.10.24 | Novo Nordisk Underperform | Bernstein Research | |
| 15.10.24 | Novo Nordisk Neutral | UBS AG | |
| 10.10.24 | Novo Nordisk Buy | Deutsche Bank AG | |
Werbung
Werbung
